Phase 2 Macular Oedema Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME）
Diabetic Macular Oedema
Innovent Biologics Technology Limited (Shanghai R&D Center)150 enrolled1 locationNCT06908876
Recruiting
Phase 2
Avastin versus Triamcinolone for Diabetic Macular Edema at the time of Cataract Surgery
CataractsDiabetic Macular Oedema
Royal Victorian Eye and Ear Hospital100 enrolled1 locationACTRN12611000888965
Recruiting
Phase 2
A phase II, 12 month, randomized, sham-controlled trial of ranibizumab (Lucentis) combined with grid laser compared with laser alone for the treatment of recalcitrant, diabetic macular oedema.
Diabetic RetinopathyDiabetic Macular Oedema
Novartis40 enrolled1 locationACTRN12611000063910
Completed
Phase 2
Efficacy and safety of Methotrexate injections into the eye for inflammatory diseases of the eye.
Visual loss due to macular oedema secondary to uveitis
Royal Victorian Eye and Ear Hospital10 enrolled1 locationACTRN12610001004055
Completed
Phase 2Phase 3
Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema (TDMX study)
Diabetic Macular Oedema
Professor Mark Gillies64 enrolled1 locationACTRN12605000244606
Completed
Phase 2Phase 3
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema that Persists after Laser Treatment (TDMO)
Diabetic Macular Oedema
Professor Mark Gillies70 enrolled1 locationACTRN12605000211662